News
BIO-B
337.15
0.00%
0.00
Weekly Report: what happened at BIO B last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at BIO B last week (0212-0216)?
Weekly Report · 02/19 09:06
Weekly Report: what happened at BIO B last week (0205-0209)?
Weekly Report · 02/12 09:05
Weekly Report: what happened at BIO B last week (0129-0202)?
Weekly Report · 02/05 09:06
Weekly Report: what happened at BIO B last week (0122-0126)?
Weekly Report · 01/29 09:05
Weekly Report: what happened at BIO B last week (0115-0119)?
Weekly Report · 01/22 09:06
Weekly Report: what happened at BIO B last week (0108-0112)?
Weekly Report · 01/15 09:05
Weekly Report: what happened at BIO B last week (0101-0105)?
Weekly Report · 01/08 09:05
Weekly Report: what happened at BIO B last week (1225-1229)?
Weekly Report · 01/01 09:05
Weekly Report: what happened at BIO B last week (1218-1222)?
Weekly Report · 12/25/2023 09:06
Bio Rad Laborato: Statement of changes in beneficial ownership of securities
Press release · 12/24/2023 05:48
More
Webull provides a variety of real-time BIO-B stock news. You can receive the latest news about Bio Rad Laborato through multiple platforms. This information may help you make smarter investment decisions.
About BIO-B
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.